1. Home
  2. COHN vs NSPR Comparison

COHN vs NSPR Comparison

Compare COHN & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

N/A

Current Price

$11.99

Market Cap

38.7M

Sector

Finance

ML Signal

N/A

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$0.84

Market Cap

33.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COHN
NSPR
Founded
1999
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.7M
33.7M
IPO Year
2003
2009

Fundamental Metrics

Financial Performance
Metric
COHN
NSPR
Price
$11.99
$0.84
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
16.3K
45.9K
Earning Date
05-01-2026
05-04-2026
Dividend Yield
4.35%
N/A
EPS Growth
5537.50
N/A
EPS
1.36
N/A
Revenue
$275,564,000.00
$2,310,000.00
Revenue This Year
N/A
$57.98
Revenue Next Year
N/A
$95.41
P/E Ratio
$8.80
N/A
Revenue Growth
246.19
N/A
52 Week Low
$9.19
$0.63
52 Week High
$32.60
$2.57

Technical Indicators

Market Signals
Indicator
COHN
NSPR
Relative Strength Index (RSI) 42.41 68.17
Support Level $10.90 $0.69
Resistance Level $16.17 $1.04
Average True Range (ATR) 0.78 0.05
MACD -0.16 0.02
Stochastic Oscillator 16.49 87.56

Price Performance

Historical Comparison
COHN
NSPR

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: